Dị ka nnyocha ọhụrụ e bipụtara na Journal of the Endocrine Society si kwuo, onye nchọpụta chọpụtara na testosterone na-abawanye ohere nke ụbụrụ prostate ma na-eme ka mmetụta nke mkpughe kemịkalụ carcinogenic dị na oke. Ọ gbara ndị ikom ndị a na-achọpụtabeghị na ha nwere hypogonadism kpachara anya mgbe ha na-enye ọgwụgwọ testosterone. Endocrinology.
N'ime afọ iri gara aga, iji testosterone amụbawo n'etiti ndị okenye na-achọ ịkwalite ume na inwe mmetụta dị obere. Otu nnyocha e bipụtara na Journal of Clinical Endocrinology and Metabolism chọpụtara na n'agbanyeghị nchegbu banyere ihe ize ndụ obi nwere ike ime, ọnụ ọgụgụ ndị ikom America na-amalite ọgwụgwọ testosterone fọrọ nke nta ka ọ bụrụ okpukpu anọ kemgbe 2000.
The Endocrine Society’s clinical practice guidelines for the treatment of testosterone in adult men recommend that testosterone be prescribed only for men with significantly low hormone levels, decreased libido, erectile dysfunction, or other symptoms of hypogonadism. Online: http://www.endocrine.org/~/ media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/FINAL-Androgens-in-Men-Standalone.pdf
"Ọmụmụ ihe a na-egosi na testosterone n'onwe ya bụ carcinogen na-adịghị ike na oke ụmụ nwoke," ka onye edemede nke ọmụmụ na Dr. Maarten C. Bosland nke DVSc si na Mahadum Illinois na Chicago kwuru. “Mgbe ejikọtara ya na kemịkalụ carcinogenic, testosterone na-emepụta ebe kwesịrị ekwesị maka mmepe etuto ahụ. Ọ bụrụ na achọpụtara otu nchọpụta ndị a n'ime mmadụ, mgbe ahụ nsogbu ahụike ọha na eze ga-abụ nnukwu ihe kpatara ya. "
Ọmụmụ nzaghachi dose abụọ nyochara ọrịa kansa prostate na oke. Enyere oke testosterone site na ngwaọrụ etinyere ntọhapụ. Tupu ịgbanye testosterone n'ime oke, a na-agbanye ụfọdụ anụmanụ na kemịkalụ carcinogenic N-nitroso-N-methylurea (MNU). Atụnyere oke ndị a na otu njikwa natara MNU mana etinyere ngwaọrụ ntọhapụ efu.
N'ime oke ndị natara testosterone na-enweghị kemịkalụ carcinogenic, 10% ruo 18% mepụtara ọrịa kansa prostate. Ọgwụgwọ Testosterone naanị emeghị ka ọ pụta ìhè kpọmkwem etuto ahụ na saịtị ndị ọzọ, ma e jiri ya tụnyere oke nchịkwa, ọ kpatara mmụba dị ukwuu na ọnụ ọgụgụ nke oke nwere ụbụrụ ọjọọ na saịtị ọ bụla. Mgbe oke na-ekpughere testosterone na carcinogens, ọgwụgwọ a na-ebute 50% ruo 71% nke oke iji mepụta ọrịa kansa prostate. Ọbụlagodi na ọnụọgụ homonụ dị oke ala iji mee ka ọkwa testosterone dị n'ọbara dịkwuo elu, ọkara ụmụ oke ka na-ata ahụhụ site na etuto prostate. Ụmụ anụmanụ ekpughere na kemịkalụ carcinogenic mana ọ bụghị testosterone etoliteghị ọrịa kansa prostate.
"N'ihi na mmepe nke ọgwụgwọ testosterone dị ọhụrụ, na ọrịa cancer prostate bụ ọrịa na-eji nwayọọ nwayọọ na-eto eto, ọ dịghị ugbu a data iji chọpụta ma testosterone na-abawanye ohere nke ọrịa cancer prostate na ụmụ mmadụ," Boslan kwuru. "Ọ bụ ezie na a na-eduzi ọmụmụ ihe mmadụ, ọ bụ ihe amamihe dị na ya iji belata ọgwụ testosterone nye ndị ikom nwere mgbaàmà hypogonadism na-agwọ ọrịa, na izere ndị ikom na-eji testosterone maka nzube ndị na-abụghị ọgwụgwọ, gụnyere ịza akara ngosi nke ịka nká."
Ọmụmụ ihe akpọrọ "Ọgwụgwọ Testosterone bụ onye na-akwalite tumor dị irè maka prostate oke" ka ebipụtala na ntanetị tupu ebipụta ya.
Nweta akụkọ sayensị kachasị ọhụrụ site na akwụkwọ akụkọ email efu nke ScienceDaily, emelitere kwa ụbọchị na kwa izu. Ma ọ bụ lelee ndepụta akụkọ emelitere kwa elekere na onye na-agụ RSS gị:
Gwa anyị ihe ị chere banyere ScienceDaily-anyị na-anabata ma okwu dị mma na nke na-adịghị mma. Enwere nsogbu ọ bụla iji webụsaịtị a? nsogbu?
Oge nzipu: Sep-09-2021